776 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
BMY Bristol-Myers Squibb Company $61.3 $100.03B Uptrend
Article Searches
What Awaits Boston Scientific (BSX) in Q2 Earnings? http://www.zacks.com/stock/news/224050/what-awaits-boston-scientific-bsx-in-q2-earnings?cid=CS-ZC-FT-224050 Jul 19, 2016 - Boston Scientific Corporation (BSX) is scheduled to report its second-quarter 2016 results before the opening bell on Jul 28.
J&J (JNJ) Stock Gains on Q2 Earnings and Improved Outlook http://www.zacks.com/stock/news/223958/jj-jnj-stock-gains-on-q2-earnings-and-improved-outlook?cid=CS-ZC-FT-223958 Jul 19, 2016 - Johnson & Johnson's (JNJ) shares were up in pre-market trading with the company beating on all fronts and raising its guidance for 2016.
Hologic (HOLX) Q3 Earnings: A Surprise in the Cards? http://www.zacks.com/stock/news/223915/hologic-holx-q3-earnings-a-surprise-in-the-cards?cid=CS-ZC-FT-223915 Jul 19, 2016 - Hologic (HOLX) has a Zacks Rank #2 (Buy) which along with a 0.00 % ESP makes surprise prediction difficult.
Illumina (ILMN) to Report Q2 Earnings: What's in the Cards? http://www.zacks.com/stock/news/223906/illumina-ilmn-to-report-q2-earnings-whats-in-the-cards?cid=CS-ZC-FT-223906 Jul 19, 2016 - Illumina (ILMN) has a Zacks Rank #4 (Sell), which along with an ESP of 0.00% makes surprise prediction difficult.
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S. http://www.zacks.com/stock/news/223881/valeants-vrx-brodalumab-bla-up-for-review-in-the-us?cid=CS-ZC-FT-223881 Jul 18, 2016 - Valeant Pharmaceuticals International, Inc.'s (VRX) Biologic License Application (BLA) for brodalumab is up for review by an FDA panel.
Edwards Lifesciences (EW) Q2 Earnings: Will It Be a Miss? http://www.zacks.com/stock/news/223858/edwards-lifesciences-ew-q2-earnings-will-it-be-a-miss?cid=CS-ZC-FT-223858 Jul 18, 2016 - Edwards (EW) has a Zacks Rank #4 (Sell), which along with a negative ESP of -1.43% makes surprise prediction difficult.
Top 7 Research Reports for July 18, 2016 http://www.zacks.com/research-daily/86187/top-7-research-reports-for-july-18-2016?cid=CS-ZC-FT-86187 Jul 18, 2016 - Top 7 Research Reports for July 18, 2016
Bayer Expands Drug Discovery Collaboration with X-Chem http://www.zacks.com/stock/news/223358/bayer-expands-drug-discovery-collaboration-with-x-chem?cid=CS-ZC-FT-223358 Jul 13, 2016 - Bayer (BAYRY) inked an expanded global drug discovery deal with X-Chem, Inc. across multiple therapeutic areas and target classes.
Top 7 Research Reports for July 13, 2016 http://www.zacks.com/research-daily/85831/top-7-research-reports-for-july-13-2016?cid=CS-ZC-FT-85831 Jul 13, 2016 - Top 7 Research Reports for July 13, 2016
Bull of the Day: Bristol-Myers Squibb (BMY) http://www.zacks.com/commentary/84704/bull-of-the-day-bristol-myers-squibb-bmy?cid=CS-ZC--84704 Jul 05, 2016 - Bull of the Day: Bristol-Myers Squibb (BMY)

Pages: 1...7172737475767778

<<<Page 76>